Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #72,201 to #72,250.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Hepatitis C other imaging findings (7 revisions)
  2. Hepatitis future or investigational therapies (7 revisions)
  3. Hepatitis laboratory findings (7 revisions)
  4. Hepatocellular adenoma future or investigational therapies (7 revisions)
  5. Hepatocellular carcinoma cost-effectiveness of therapy (7 revisions)
  6. Hepatocellular carcinoma future or investigational therapies (7 revisions)
  7. Hepatocellular carcinoma stagin (7 revisions)
  8. Hepatolithiasis (patient information) (7 revisions)
  9. Hepatopulmonary syndrome risk factors (7 revisions)
  10. Hepatorenal syndrome CT (7 revisions)
  11. Hepatosplenic T cell lymphoma laboratory tests (7 revisions)
  12. Hereditary nonpolyposis colorectal cancer electrocardiogram (7 revisions)
  13. Hereditary pancreatitis classification (7 revisions)
  14. Hereditary pancreatitis medical therapy (7 revisions)
  15. Hereditary pancreatitis secondary prevention (7 revisions)
  16. Hereditary pancreatitis surgery (7 revisions)
  17. Hereditary spherocytosis primary prevention (7 revisions)
  18. Hernia causes (7 revisions)
  19. Herpes zoster other imaging findings (7 revisions)
  20. Hetacillin (7 revisions)
  21. Hexokinase deficiency (7 revisions)
  22. Hip dysplasia (human) (7 revisions)
  23. Hirschsprung's disease echocardiography or ultrasound (7 revisions)
  24. Hirschsprung's disease electrocardiogram (7 revisions)
  25. Histoplasmosis surgery (7 revisions)
  26. Hodgkin's lymphoma cost-effectiveness of therapy (7 revisions)
  27. Hodgkin's lymphoma future or investigational therapies (7 revisions)
  28. Hormone therapy (7 revisions)
  29. Horner's syndrome (patient information) (7 revisions)
  30. Horseshoe kidney causes (7 revisions)
  31. Horseshoe kidney laboratory findings (7 revisions)
  32. Horseshoe kidney primary prevention (7 revisions)
  33. Hospital-acquired pneumonia cost-effectiveness of therapy (7 revisions)
  34. Hospital rapid response team (7 revisions)
  35. Erectile dysfunction epidemiology and demographics (7 revisions)
  36. Erectile dysfunction medical therapy (7 revisions)
  37. Erectile dysfunction risk factors (7 revisions)
  38. ErrorReportTesting (7 revisions)
  39. Erysipelas cost-effectiveness of therapy (7 revisions)
  40. Erysipelas future or investigational therapies (7 revisions)
  41. Erythrasma epidemiology and demographics (7 revisions)
  42. Erythrasma historical perspective (7 revisions)
  43. Erythrasma surgery (7 revisions)
  44. Esophageal cancer historical perspective (7 revisions)
  45. Esophageal candidiasis other diagnostic studies (7 revisions)
  46. Esophageal motility disorder (7 revisions)
  47. Esophagitis screening (7 revisions)
  48. Essential thrombocytosis causes (7 revisions)
  49. Essential thrombocytosis other diagnostic studies (7 revisions)
  50. Ester (7 revisions)

View ( | ) (20 | 50 | 100 | 250 | 500)